Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELIXIRS: Lixisenatide vs Insulin Glulisine on Renal Physiology in T2DM
NCT02276196Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2014
- Primary completion
- Apr 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of lixisenatide in type 2 diabetes mellitus (T2DM), sponsored by Amsterdam University Medical Center. Started Sep 2014; status: completed.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02276196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02276196.